The CML-specific P210 bcr/abl protein, unlike v-abl, does not transform NIH/3T3 fibroblasts.

The v-abl oncogene of the Abelson murine leukemia virus (A-MuLV) is known to efficiently transform NIH/3T3 fibroblasts in vitro and to cause an acute lymphosarcoma in susceptible murine hosts. The role of its relative, the bcr/abl gene product, in the etiology of human chronic myelogenous leukemia (CML) remains speculative. To assess the transforming properties of the bcr/abl gene product, complementary DNA clones encoding the CML-specific P210 bcr/abl protein were expressed in NIH/3T3 fibroblasts. In contrast to the v-abl oncogene product P160, the P210 bcr/abl gene product did not transform NIH/3T3 cells. Cell lines were isolated that expressed high levels of the P210 bcr/abl protein but were morphologically normal. During the course of these experiments, a transforming recombinant of bcr/abl was isolated which fuses gag determinants derived from helper virus to the NH2-terminus of the bcr/abl protein. This suggests that a property of viral gag sequences, probably myristylation-dependent membrane localization, must be provided to bcr/abl for it to transform fibroblasts.

[1]  D. Baltimore,et al.  Neuronal pp60c-src contains a six-amino acid insertion relative to its non-neuronal counterpart. , 1987, Science.

[2]  M. Greaves,et al.  A novel abl protein expressed in Philadelphia chromosome positive acute lymphoblastic leukaemia positive acute lymphoblastic leukaemia , 1987, Nature.

[3]  R. Kurzrock,et al.  A novel c-abl protein product in Philadelphia-positive acute lymphoblastic leukaemia , 1987, Nature.

[4]  O. Witte,et al.  Unique forms of the abl tyrosine kinase distinguish Ph1-positive CML from Ph1-positive ALL. , 1987, Science.

[5]  G. Daley,et al.  Overlapping cDNA clones define the complete coding region for the P210c-abl gene product associated with chronic myelogenous leukemia cells containing the Philadelphia chromosome. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[6]  R. Germain,et al.  Efficient cell surface expression of class II MHC molecules in the absence of associated invariant chain , 1986, The Journal of experimental medicine.

[7]  Bruce A. Roe,et al.  Alternative splicing of RNAs transcribed from the human abl gene and from the bcr-abl fused gene , 1986, Cell.

[8]  G. Daley,et al.  The chronic myelogenous leukemia-specific P210 protein is the product of the bcr/abl hybrid gene. , 1986, Science.

[9]  G. Daley,et al.  Alternative 5′ exons in c-abl mRNA , 1986, Cell.

[10]  R. Axel,et al.  The isolation and nucleotide sequence of a cDNA encoding the T cell surface protein T4: a new member of the immunoglobulin gene family , 1985, Cell.

[11]  E. Canaani,et al.  Fused transcript of abl and bcr genes in chronic myelogenous leukaemia , 1985, Nature.

[12]  E. Brown,et al.  Human GM-CSF: molecular cloning of the complementary DNA and purification of the natural and recombinant proteins. , 1985, Science.

[13]  F. Cross,et al.  Fine structural mapping of a critical NH2-terminal region of p60src. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[14]  O. Witte,et al.  Cell lines and clinical isolates derived from Ph1-positive chronic myelogenous leukemia patients express c-abl proteins with a common structural alteration. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[15]  N. Rosenberg,et al.  A membrane-associated, carbohydrate-modified form of the v-abl protein that cannot be phosphorylated in vivo or in vitro , 1984, Journal of virology.

[16]  R. Davis,et al.  Only site-directed antibodies reactive with the highly conserved src-homologous region of the v-abl protein neutralize kinase activity , 1984, Journal of virology.

[17]  Susan M. Watanabe,et al.  An alteration of the human c-abl protein in K562 leukemia cells unmasks associated tyrosine kinase activity , 1984, Cell.

[18]  A. Schultz,et al.  Myristylation of gag-onc fusion proteins in mammalian transforming retroviruses. , 1984, Virology.

[19]  J. Stephenson,et al.  Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22 , 1984, Cell.

[20]  E. Reddy,et al.  Nucleotide sequence of Abelson murine leukemia virus genome: structural similarity of its transforming gene product to other onc gene products with tyrosine-specific kinase activity. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[21]  D. Baltimore,et al.  Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus , 1983, Cell.

[22]  H. Hanafusa,et al.  Only membrane-associated RSV src proteins have amino-terminally bound lipid , 1983, Nature.

[23]  S. Ziegler,et al.  Differentiation of cloned populations of immature B cells after transformation with abelson murine leukemia virus , 1983, Cell.

[24]  S. Latt,et al.  Cloning and analysis of reverse transcript P160 genomes of Abelson murine leukemia virus , 1983, Journal of virology.

[25]  Jonathan A. Cooper,et al.  The transforming proteins of Rous sarcoma virus, Harvey sarcoma virus and Abelson virus contain tightly bound lipid , 1982, Cell.

[26]  C. Tabin,et al.  Transfection of Fibroblasts by Cloned Abelson Murine Leukemia Virus DNA and Recovery of Transmissible Virus by Recombination with Helper Virus , 1982, Journal of virology.

[27]  P Berg,et al.  Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter. , 1982, Journal of molecular and applied genetics.

[28]  D. Baltimore,et al.  Intramolecular integration within Moloney murine leukemia virus DNA , 1981, Journal of Virology.

[29]  M. Gefter,et al.  Multiple expression of Ig lambda-chain encoding RNA species in murine plasmacytoma cells. , 1981, Journal of immunology.

[30]  C. Lozzio,et al.  Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome. , 1975, Blood.

[31]  J. Rowley.  A New Consistent Chromosomal Abnormality in Chronic Myelogenous Leukaemia identified by Quinacrine Fluorescence and Giemsa Staining , 1973, Nature.

[32]  H. Abelson,et al.  Influence of prednisolone on Moloney leukemogenic virus in BALB-c mice. , 1970, Cancer research.